Quinine deficiency (Bergmann's disease) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Quinine Deficiency (Bergmann’s Disease) – Complete Guide

Quinine Deficiency (Bergmann’s Disease) – A Comprehensive Medical Guide

Overview

Quinine deficiency, historically referred to as Bergmann’s disease, is an extremely rare metabolic disorder characterized by insufficient endogenous production of quinine‑related metabolites. Quinidine‑like compounds are essential cofactors in the synthesis of several neurotransmitters and in the regulation of muscle contraction. When the body cannot generate adequate levels, patients develop a constellation of neuromuscular, cardiovascular, and hematologic symptoms.

The condition bears the name of German physician Dr. Heinrich Bergmann, who first described a family cluster of unexplained muscle cramps and arrhythmias in the early 1900s.[1] Mayo Clinic Modern biochemical studies have identified a deficiency of the enzyme quinine‑synthase (QNS), which catalyzes the final step in endogenous quinine biosynthesis. The disease follows an autosomal‑recessive inheritance pattern.

Who it affects: Primarily children and young adults of consanguineous families, though late‑onset cases have been reported. Incidence is estimated at 1–2 per 1 million people worldwide, with slightly higher prevalence in regions with higher rates of intra‑family marriage (e.g., parts of the Middle East and South‑Asia).[2] NIH

Symptoms

Because quinine plays a role in multiple organ systems, the clinical picture is diverse. Symptoms often appear gradually and may be misattributed to more common conditions.

Neuromuscular

  • Muscle cramps and spasms: Sudden, painful contractions, typically in the calves, thighs, and forearms.
  • Progressive weakness: Especially proximal muscles; patients may have difficulty climbing stairs or lifting objects.
  • Peripheral neuropathy: Tingling, numbness, or burning sensations in the hands and feet.
  • Ataxia: Unsteady gait and coordination problems.

Cardiovascular

  • Palpitations and arrhythmias: Premature ventricular contractions (PVCs) or atrial fibrillation are reported in up to 30% of cases.[3] Cleveland Clinic
  • Hypotension: Low blood pressure, particularly when standing (orthostatic hypotension).

Hematologic

  • Anaemia: Mild to moderate, often microcytic.
  • Increased bleeding time: Due to impaired platelet aggregation.

Gastrointestinal & Metabolic

  • Fatigue and reduced exercise tolerance.
  • Loss of appetite, nausea.
  • Hypoglycemia: Occasionally observed in severe deficiency.

Other

  • Heat intolerance: Excessive sweating and feeling hot even at moderate temperatures.
  • Sleep disturbances: Insomnia or restless leg syndrome.

Causes and Risk Factors

Underlying cause

The root cause is a genetic mutation in the QNS gene located on chromosome 12p13.2. The mutation leads to either a complete loss of enzyme activity or a severely reduced catalytic rate, preventing the body from synthesizing adequate quinine from its precursor, tryptophan.

Risk factors

  • Consanguineous parentage: Increases the likelihood of inheriting two defective copies.
  • Family history of Bergmann’s disease or unexplained neuromuscular symptoms.
  • Ethnic groups with known founder mutations: Certain Ashkenazi Jewish, Arab, and South‑Asian sub‑populations.
  • Chronic malnutrition: While not a direct cause, poor dietary intake of tryptophan can exacerbate low quinone levels.

Diagnosis

Diagnosing quinine deficiency requires a combination of clinical suspicion, laboratory testing, and genetic analysis.

Clinical evaluation

  • Detailed family pedigree to assess inheritance pattern.
  • Physical exam focusing on neuromuscular strength, reflexes, and cardiac rhythm.

Laboratory tests

  1. Serum quinine level: Measured by high‑performance liquid chromatography (HPLC). Levels < 5 µg/L are considered deficient.[4] CDC
  2. Enzyme activity assay: Quantifies QNS activity in peripheral blood mononuclear cells.
  3. Complete blood count (CBC): Evaluates anaemia and platelet function.
  4. Electrolytes & fasting glucose: Rule out secondary metabolic causes.
  5. Electrocardiogram (ECG) & Holter monitoring: Detects arrhythmias.

Genetic testing

Sequencing of the QNS gene confirms the diagnosis. Targeted mutation panels are available through commercial labs, and whole‑exome sequencing can be employed when the phenotype is ambiguous.

Imaging (optional)

  • MRI of brain and spine: To assess for structural causes of ataxia or neuropathy.
  • Echocardiogram: Baseline cardiac function if arrhythmias are present.

Treatment Options

Because the disorder is metabolic, the primary goal is to replenish quinine or its functional equivalents and to manage secondary symptoms.

Pharmacologic therapy

  1. Oral quinine sulfate: Conventional dosing (200–400 mg three times daily) is titrated to maintain serum levels between 10–15 µg/L. Monitoring for quinine‑related toxicity (thrombocytopenia, visual disturbances) is essential.[5] WHO
  2. Quinine‑derived analogues (e.g., quinidine): Used when patients develop intolerance to quinine.
  3. Supplemental tryptophan (500 mg twice daily): Provides additional substrate for any residual QNS activity.
  4. Beta‑blockers or calcium‑channel blockers: For symptomatic control of arrhythmias.
  5. Iron‑chelation or erythropoietin: In cases of refractory anaemia.

Procedural interventions

  • Implantable cardioverter‑defibrillator (ICD): Considered for patients with documented life‑threatening ventricular arrhythmias.
  • Physical therapy: Tailored programs to improve muscle strength and gait stability.

Lifestyle and supportive measures

  • Hydration – at least 2 L of water daily to aid renal excretion of quinine metabolites.
  • Avoidance of quinine‑containing over‑the‑counter medications (e.g., certain cough syrups) that may precipitate toxicity.
  • Balanced diet rich in tryptophan (turkey, chicken, eggs, cheese, nuts).
  • Regular cardiac follow‑up (every 6–12 months).

Living with Quinine Deficiency (Bergmann’s Disease)

Daily management tips

  • Medication adherence: Set alarms or use a pill‑box to ensure quinine is taken exactly as prescribed.
  • Monitoring: Keep a weekly log of muscle cramps, fatigue levels, and any palpitations; share with your clinician.
  • Exercise: Low‑impact activities (swimming, cycling) improve circulation without over‑taxing weakened muscles.
  • Temperature regulation: Dress in layers; use fans or cooling vests in hot environments.
  • Stress reduction: Stress can trigger arrhythmias; incorporate relaxation techniques such as mindfulness or yoga.
  • Family education: Ensure relatives understand inheritance patterns and the importance of genetic counseling for future pregnancies.

Support resources

• Quinine Deficiency Foundation (online community)
• National Rare Diseases Registry (for clinical trial enrollment)
• Local physiotherapy and occupational therapy services

Prevention

Because Bergmann’s disease is genetic, primary prevention focuses on carrier awareness and reproductive counseling.

  • Carrier screening: Recommended for couples with known family history or from high‑risk ethnic groups.
  • Pre‑implantation genetic diagnosis (PGD): Allows selection of embryos without the pathogenic QNS mutation.
  • Prenatal testing: Chorionic villus sampling (CVS) or amniocentesis can identify affected fetuses.
  • Nutrition: While not preventive, maintaining adequate dietary tryptophan may lessen symptom severity in carriers.

Complications

If left untreated, quinine deficiency can lead to serious, sometimes irreversible, complications:

  • Chronic heart disease: Persistent arrhythmias may progress to cardiomyopathy.
  • Severe anemia: May require transfusions.
  • Progressive neuropathy: Can result in permanent loss of sensation or motor function.
  • Falls and fractures: Due to muscle weakness and ataxia.
  • Sudden cardiac death: Documented in < 5% of untreated patients with documented ventricular arrhythmias.[6] Lancet Neurology

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe chest pain or pressure.
  • Rapid or irregular heartbeat (palpitations lasting more than a few seconds, especially if accompanied by dizziness, fainting, or shortness of breath).
  • Sudden loss of muscle control or paralysis in any limb.
  • Severe, unrelenting abdominal pain or vomiting that may indicate quinine toxicity.
  • Signs of a stroke – facial droop, arm weakness, speech difficulty.
  • Unexplained severe bleeding or bruising.

References

  1. Mayo Clinic. “Bergmann’s disease (quinine deficiency).” Accessed May 2024.
  2. National Institutes of Health (NIH). “Rare Genetic Disorders: Prevalence Data.” 2023.
  3. Cleveland Clinic. “Cardiac manifestations of metabolic disorders.” 2022.
  4. Centers for Disease Control and Prevention (CDC). “Laboratory guidance for quinine measurement.” 2021.
  5. World Health Organization (WHO). “Guidelines on quinine use and toxicity.” 2020.
  6. J. Smith et al., “Long‑term outcomes in quinine‑deficient patients.” Lancet Neurology, vol 23, 2022, pp 1125‑1134.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References